Manulife (Manufacturers Life Insurance)’s Xencor XNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$976K Sell
80,899
-2,043
-2% -$25.4K ﹤0.01% 1844
2025
Q4
$1.25M Sell
82,942
-12,165
-13% -$182K ﹤0.01% 1746
2025
Q3
$1.12M Sell
95,107
-9,543
-9% -$82.8K ﹤0.01% 1801
2025
Q2
$823K Buy
104,650
+3,243
+3% +$29.1K ﹤0.01% 1913
2025
Q1
$1.08M Buy
101,407
+1,034
+1% +$17.1K ﹤0.01% 1777
2024
Q4
$2.31M Sell
100,373
-9,343
-9% -$215K ﹤0.01% 1498
2024
Q3
$2.21M Sell
109,716
-10,272
-9% -$193K ﹤0.01% 1515
2024
Q2
$2.27M Buy
119,988
+22,107
+23% +$475K ﹤0.01% 1457
2024
Q1
$2.17M Buy
97,881
+14,290
+17% +$309K ﹤0.01% 1489
2023
Q4
$1.77M Sell
83,591
-553
-0.7% -$10.5K ﹤0.01% 1509
2023
Q3
$1.7M Buy
84,144
+4,133
+5% +$94K ﹤0.01% 1496
2023
Q2
$2M Sell
80,011
-6,813
-8% -$185K ﹤0.01% 1414
2023
Q1
$2.42M Buy
86,824
+13,878
+19% +$428K ﹤0.01% 1351
2022
Q4
$1.87M Buy
72,946
+90
+0.1% +$2.52K ﹤0.01% 1405
2022
Q3
$1.87M Sell
72,856
-493
-0.7% -$14.1K ﹤0.01% 1401
2022
Q2
$2M Sell
73,349
-261
-0.4% -$6.44K ﹤0.01% 1422
2022
Q1
$2M Buy
73,610
+44,693
+155% +$1.44M ﹤0.01% 1506
2021
Q4
$1.17K Sell
28,917
-328
-1% -$12.4K ﹤0.01% 1736
2021
Q3
$955K Sell
29,245
-2,974
-9% -$97.7K ﹤0.01% 1872
2021
Q2
$1.11M Buy
32,219
+723
+2% +$28.7K ﹤0.01% 1937
2021
Q1
$1.36M Sell
31,496
-1,890
-6% -$89.5K ﹤0.01% 1720
2020
Q4
$1.46M Buy
33,386
+1,204
+4% +$49.8K ﹤0.01% 1650
2020
Q3
$1.25M Sell
32,182
-919
-3% -$31.9K ﹤0.01% 1572
2020
Q2
$1.07M Buy
33,101
+2,711
+9% +$83.1K ﹤0.01% 1587
2020
Q1
$908K Buy
30,390
+1,740
+6% +$57.6K ﹤0.01% 1548
2019
Q4
$985K Sell
28,650
-927
-3% -$33.9K ﹤0.01% 1689
2019
Q3
$1.01M Sell
29,577
-108
-0.4% -$4.31K ﹤0.01% 1635
2019
Q2
$1.22M Sell
29,685
-962
-3% -$31.6K ﹤0.01% 1556
2019
Q1
$952K Buy
30,647
+1,866
+6% +$62.1K ﹤0.01% 1729
2018
Q4
$1.04M Sell
28,781
-1,499
-5% -$55K ﹤0.01% 1573
2018
Q3
$1.18M Sell
30,280
-4,262
-12% -$174K ﹤0.01% 1701
2018
Q2
$1.28M Buy
34,542
+5,626
+19% +$194K ﹤0.01% 1725
2018
Q1
$867K Sell
28,916
-824
-3% -$21.5K ﹤0.01% 1939
2017
Q4
$652K Buy
29,740
+147
+0.5% +$3.19K ﹤0.01% 2138
2017
Q3
$678K Sell
29,593
-178
-0.6% -$3.95K ﹤0.01% 2057
2017
Q2
$629K Buy
29,771
+1,673
+6% +$37.5K ﹤0.01% 2115
2017
Q1
$672K Buy
28,098
+4,052
+17% +$97.7K ﹤0.01% 1983
2016
Q4
$633K Buy
24,046
+1,700
+8% +$40.9K ﹤0.01% 1957
2016
Q3
$547K Sell
22,346
-389
-2% -$8.23K ﹤0.01% 2025
2016
Q2
$431K Buy
22,735
+3,309
+17% +$45.4K ﹤0.01% 2139
2016
Q1
$250K Buy
19,426
+94
+0.5% +$1.11K ﹤0.01% 2439
2015
Q4
$282 Buy
19,332
+252
+1% +$3.39K ﹤0.01% 2407
2015
Q3
$234 Buy
19,080
+433
+2% +$8.47K ﹤0.01% 2515
2015
Q2
$409 Buy
18,647
+8,174
+78% +$139K ﹤0.01% 2264
2015
Q1
$161 Sell
10,473
-343
-3% -$5.41K ﹤0.01% 2908
2014
Q4
$173 Buy
10,816
+1,313
+14% +$15.2K ﹤0.01% 2742
2014
Q3
$89 Buy
9,503
+3,431
+57% +$34.7K ﹤0.01% 3158
2014
Q2
$70K Buy
+6,072
New +$59.6K ﹤0.01% 3211

Other funds holding XNCR

Manulife (Manufacturers Life Insurance)'s XNCR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Xencor (XNCR) stake by 2.5% in Q1 2026, selling an estimated $25.4K and leaving 80,899 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Manulife (Manufacturers Life Insurance) first reported a position in XNCR in Q2 2014 and has held it in 48 quarters since. The position peaked at $2.42M in Q1 2023. 203 funds tracked by Wall St. Rank hold XNCR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 80,899 shares of Xencor worth $976K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,043 Xencor shares in Q1 2026, an estimated $25.4K.
  • Xencor made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1844 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Xencor in Q2 2014 and has held it in 48 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Xencor position peaked at $2.42M in Q1 2023.
  • 203 funds tracked by Wall St. Rank held Xencor as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.